Literature DB >> 22712643

Changes in activity patterns after the oral administration of brotizolam in institutionalized elderly patients with dementia.

Xiao Yan Liao1, Miyae Yamakawa, Shunji Suto, Kazue Shigenobu, Kiyoko Makimoto.   

Abstract

BACKGROUND: Little is known about the side effects of sedative-hypnotic agents in elderly dementia patients with sleep disorders. The present study describes activity pattern changes after a single dose of brotizolam in elderly patients with dementia.
METHODS: We conducted retrospective analysis of prospectively collected data from a case series at Asakayama Hospital (Osaka, Japan) between September 2008 and September 2009. Around-the-clock movements of dementia patients who were administered a single dose of brotizolam were recorded by the integrated circuit tag monitoring system during a 4-week baseline and 7-day peri-administration period. Diurnal and nocturnal activity levels and the onset times of the least-active and most-active phases were then measured.
RESULTS: Seven patients (four men, three women; age range 59-85 years) were analyzed. All seven patients had disturbed activity patterns during the peri-administration period. Compared with the pre-administration period, the incidence of reversed rest-activity pattern increased significantly in the post-administration period, as measured by the distance moved per hour (P < 0.000). Patients with advanced stages of dementia had prolonged and delayed activity responses.
CONCLUSIONS: Findings showed changes in activity levels and reversed active/resting phases after a single dose of brotizolam in elderly patients with dementia. Use of brotizolam in elderly patients with dementia, especially in advanced stages, calls for closer attention and longer observation periods.
© 2012 The Authors. Psychogeriatrics © 2012 Japanese Psychogeriatric Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22712643     DOI: 10.1111/j.1479-8301.2011.00401.x

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  2 in total

1.  Safety of brotizolam in hospitalized patients.

Authors:  Ophir Lavon; Shmuel Bejel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-22       Impact factor: 2.953

Review 2.  Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature.

Authors:  Michaela Defrancesco; Josef Marksteiner; W Wolfgang Fleischhacker; Imrich Blasko
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.